Factors associated with a reduced CD4 lymphocyte count response to HAART despite full viral suppression in the EuroSIDA study.
about
CCL3L1-CCR5 Genotype Improves the Assessment of AIDS Risk in HIV-1-Infected IndividualsUse of observational data in evaluating treatments: antiretroviral therapy and HIV.Naturally-acquired influenza-specific CD4+ T-cell proliferative responses are impaired in HIV-infected African adults.Utility of CD4 cell counts for early prediction of virological failure during antiretroviral therapy in a resource-limited settingSex differences in HIV outcomes in the highly active antiretroviral therapy era: a systematic reviewInitiation of antiretroviral therapy at high CD4 cell counts: does it reduce the risk of cardiovascular disease?Frequency and impact of suboptimal immune recovery on first-line antiretroviral therapy within the International Epidemiologic Databases to Evaluate AIDS in East Africa.Effect of early versus deferred antiretroviral therapy for HIV on survival.Predictors of suboptimal CD4 response among women achieving virologic suppression in a randomized antiretroviral treatment trial, Africa.Time to immunologic recovery and determinant factors among adults who initiated ART in Felege Hiwot Referral Hospital, northwest Ethiopia.Clinical predictors of immune reconstitution following combination antiretroviral therapy in patients from the Australian HIV Observational Database.Maraviroc intensification in patients with suppressed HIV viremia has limited effects on CD4+ T cell recovery and gene expression.Factors associated with paradoxical immune response to antiretroviral therapy in HIV infected patients: a case control study.Absolute CD4+ T-lymphocyte count as a surrogate marker of pediatric human immunodeficiency virus disease progression.Factors predicting discordant virological and immunological responses to antiretroviral therapy in HIV-1 clade C infected Zulu/Xhosa in South Africa.Gender differences in immune reconstitution: a multicentric cohort analysis in sub-Saharan Africa.Long-term mortality in HIV patients virally suppressed for more than three years with incomplete CD4 recovery: a cohort study.Effect of baseline CD4 cell counts on the clinical significance of short-term immunologic response to antiretroviral therapy in individuals with virologic suppression.Tracking a sample of patients lost to follow-up has a major impact on understanding determinants of survival in HIV-infected patients on antiretroviral therapy in Africa.Factors associated with poor immunologic response to virologic suppression by highly active antiretroviral therapy in HIV-infected womenFactors related to changes in CD4+ T-cell counts over time in patients living with HIV/AIDS: a multilevel analysis.Immune activation response in chronic HIV-infected patients: influence of Hepatitis C virus coinfection.Metabolic and anthropometric parameters contribute to ART-mediated CD4+ T cell recovery in HIV-1-infected individuals: an observational studyCD4 cell count trends after commencement of antiretroviral therapy among HIV-infected patients in Tigray, Northern Ethiopia: a retrospective cross-sectional study.Mortality after cancer diagnosis in HIV-infected individuals treated with antiretroviral therapy.Emergency department utilization among a cohort of HIV-positive injecting drug users in a Canadian settingMaraviroc Intensification of cART in Patients with Suboptimal Immunological Recovery: A 48-Week, Placebo-Controlled Randomized TrialPattern and predictors of immunologic recovery in HIV infected patients.HIV RNA suppression and immune restoration: can we do better?Study of T cell subsets and IL-7 protein expression in HIV-1-infected patients after 7 years HAARTDiscordant Treatment Responses to Combination Antiretroviral Therapy in Rwanda: A Prospective Cohort StudyPredictors of CD4 count over time among HIV patients initiated ART in Felege Hiwot Referral Hospital, northwest Ethiopia: multilevel analysis.Joint longitudinal data analysis in detecting determinants of CD4 cell count change and adherence to highly active antiretroviral therapy at Felege Hiwot Teaching and Specialized Hospital, North-west Ethiopia (Amhara Region).Poor initial CD4+ recovery with antiretroviral therapy prolongs immune depletion and increases risk for AIDS and non-AIDS diseasesImpact of age on markers of HIV-1 diseasePatient activation and improved outcomes in HIV-infected patients.Effect of age on immunological response in the first year of antiretroviral therapy in HIV-1-infected adults in West Africa.Sub-optimal CD4 reconstitution despite viral suppression in an urban cohort on antiretroviral therapy (ART) in sub-Saharan Africa: frequency and clinical significancePredictors of suboptimal virologic response to highly active antiretroviral therapy among human immunodeficiency virus-infected adolescents: analyses of the reaching for excellence in adolescent care and health (REACH) project.Association of complementary and alternative medicine use with highly active antiretroviral therapy initiation.
P2860
Q19028101-2D4F1A14-72B1-47F1-993A-AAAF02BA05D5Q30969932-9637E3BA-9707-4554-90D7-A1CAF7195498Q31065881-89F05914-5293-43A6-B0F6-2ACCC5639A88Q33349204-4B2AD027-52C2-41FB-B878-1EA56F739947Q33566578-B0504222-C92D-44D4-8A88-2D2ACA0AF967Q33649200-7952E2D9-86B9-49FA-B9D9-BFC7F51DD972Q33707759-4EEEF6A2-82D0-4928-98F5-8A3E21298C3AQ33789114-90D5436C-7D97-4EBA-B8D3-9FFFB7B32CD1Q33850736-A56A25AC-DB56-4F7E-BB39-EE324782EDC4Q33909241-B7549672-93AB-4EA9-AD65-7FF255ED77F9Q33933071-1967DC5A-E4C7-43A5-82D0-8E33339EF0FCQ33976854-C0307D99-5B87-416B-9D89-9D12A244F662Q34065045-45A1C3B2-3E9A-4C95-A491-A0FB16DD9A19Q34076185-D30BEF7E-F4A8-42BE-ADE9-9F70756B4C59Q34163380-A8896EE0-1991-4208-9DA3-C10EA874F8CCQ34170487-1C6DD2FA-DA30-4FEC-9D1D-C33A41C00331Q34332293-EAED0B5B-E69B-4AD3-8C99-D329ADBD5720Q34546011-2AC5A91C-3671-4FB6-A8D5-63EABEE05742Q34573803-EC7C9262-E0DA-4D37-BF2E-0F6F99A2AAA0Q35077997-8D9117B9-3D41-4DB0-A284-473850E6E8A9Q35088030-4C18E794-1839-4B5F-BEF4-AAB10BF5A878Q35182200-6E4B98A3-0927-4F09-97CB-41093997FE04Q35185674-EEC7FD37-6140-44BC-B972-636CCF23D2E7Q35225198-7073C50D-C6BD-48FE-94D6-92B28F275F9CQ35233148-EAC66E01-9BF1-4DDE-AFE3-B717172C5920Q35292986-EB645EE6-2787-4E70-A36F-68F941C82535Q35712284-A801DC08-6DAF-48A6-8537-C636A0401342Q35765115-6A124EC9-A0E5-4B80-AE3A-5D2814D5ED91Q35867173-156E4C86-4F2C-4A2D-AE70-1E423C5D3637Q35958380-0F806AF4-5B62-4448-85EA-4CA7CC1B3A8DQ36082736-A85221E2-C52A-4DE8-9620-AB82A662C762Q36091039-C47353F3-829F-4D50-B5DD-9F8F54A65BBFQ36311314-131BF7C3-0511-4E48-B1DA-099ABC903886Q36743092-8DFF51CE-72F9-4E44-BC4D-C83B413667BFQ36763762-198FB21B-F75D-495E-AE06-8406B5FDC8E5Q36780273-2E072246-B72F-46A5-ABFF-47439E95216DQ36992075-E59DE2F3-7658-4022-9176-81D50DDB6FC7Q37021073-1A70A400-6D2A-4E7E-B4D4-3A2BD3CFC092Q37084526-B0FAA1B7-8166-4B26-8DA3-A2654D931BD6Q37117942-E411AFF1-DE77-4415-8C68-E22C090E0079
P2860
Factors associated with a reduced CD4 lymphocyte count response to HAART despite full viral suppression in the EuroSIDA study.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
2003年论文
@zh
2003年论文
@zh-cn
name
Factors associated with a redu ...... ression in the EuroSIDA study.
@en
Factors associated with a redu ...... ression in the EuroSIDA study.
@nl
type
label
Factors associated with a redu ...... ression in the EuroSIDA study.
@en
Factors associated with a redu ...... ression in the EuroSIDA study.
@nl
prefLabel
Factors associated with a redu ...... ression in the EuroSIDA study.
@en
Factors associated with a redu ...... ression in the EuroSIDA study.
@nl
P2093
P2860
P50
P1433
P1476
Factors associated with a redu ...... ression in the EuroSIDA study.
@en
P2093
A Blaxhult
A Phillips
E Florence
EuroSIDA Study Group
P2860
P304
P356
10.1046/J.1468-1293.2003.00156.X
P577
2003-07-01T00:00:00Z